TTM
-153.3%
YoY change
−34.81pp
Trough year (2019)
-906.4%
Peak year (2021)
75.0%
Latest annual
-158.1%
Operating Margin history chart for Moderna (MRNA) from 2016 to 2025
Latest: -158.1%
Operating Margin change chart for Moderna (MRNA) from 2016 to 2025
Latest: −34.81pp
Operating Margin history table for Moderna (MRNA) from 2016 to 2025
| 2025 | -158.1% | -34.81pp | ||
| 2024 | -123.3% | -61.42pp | ||
| 2023 | -61.9% | -111.81pp | ||
| 2022 | 49.9% | -25.06pp | ||
| 2021 | 75.0% | +169.96pp | ||
| 2020 | -95.0% | +811.39pp | ||
| 2019 | -906.4% | -559.24pp | ||
| 2018 | -347.1% | -216.27pp | ||
| 2017 | -130.9% | +75.57pp | ||
| 2016 | -206.4% | — |
- 2025-158.1%-34.81pp
- 2024-123.3%-61.42pp
- 2023-61.9%-111.81pp
- 202249.9%-25.06pp
- 202175.0%+169.96pp
- 2020-95.0%+811.39pp
- 2019-906.4%-559.24pp
- 2018-347.1%-216.27pp
- 2017-130.9%+75.57pp
- 2016-206.4%—
Operating Margin values are taken from Moderna's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Margin at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported operating margin is -153.3%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual operating margin for Moderna (MRNA) came in at -158.13% – contracted 34.8 percentage points year-over-year.
74.97% stands as the all-time-high annual operating margin, posted in 2021, against a low of -906.38% during 2019.
Moderna Operating Margin by Year
Moderna Operating Margin 2025: -158.1%
In 2025, Moderna reported operating margin of -158.13%, contracted 34.8 percentage points from 2024.
Moderna Operating Margin 2024: -123.3%
Moderna operating margin in 2024 was -123.32%, contracted 61.4 percentage points from 2023.
Moderna Operating Margin 2023: -61.9%
2023's operating margin for Moderna came in at -61.90%, contracted 111.8 percentage points from 2022.
Moderna Operating Margin 2022: 49.9%
Moderna posted operating margin of 49.91% in 2022, contracted 25.1 percentage points from 2021.
Moderna Operating Margin 2021: 75.0%
Moderna operating margin in 2021 was 74.97%.
See more financial history for Moderna (MRNA).
Sector peers by Operating Margin
Healthcare peers of Moderna (MRNA), ranked by their latest operating margin
| 45.9% | |
| 45.3% | |
| 31.6% | |
| 27.6% | |
| 27.6% | |
| 26.4% | |
| 23.7% | |
| 4.2% |
- 45.9%
- 45.3%
- 31.6%
- 27.6%
- 27.6%
- 23.7%
Frequently asked questions
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation